Study to Compare the Pharmacokinetics, Safety and Tolerability of the Pediatric and Adult Branaplam Formulation in Healthy Adults and the Effect of Food on the Latter.
Clinical trial NCT05330286 · TERMINATED
Trial details
- NCT number
- NCT05330286
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-13
- Primary completion
- 2022-08-19
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.